Ascendis Pharma (ASND)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q1 2026 | |||||
| ≡ | Polen Capital Management | Add 49.63% | 601 | 0.00 | |
| Q3 2025 | |||||
| ≡ | Polen Capital Management | Add 1.73% | 47 | 0.00 | |
| Q2 2025 | |||||
| ≡ | Polen Capital Management | Buy | 2,719 | 0.00 | |
| Q1 2021 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Add 60.64% | 542,448 | 0.25 | |
| Q4 2020 | |||||
| ≡ | Stephen Mandel - Lone Pine Capital | Buy | 894,533 | 0.54 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.